230 related articles for article (PubMed ID: 9824578)
1. Intestinal permeability and inflammation in patients on NSAIDs.
Sigthorsson G; Tibble J; Hayllar J; Menzies I; Macpherson A; Moots R; Scott D; Gumpel MJ; Bjarnason I
Gut; 1998 Oct; 43(4):506-11. PubMed ID: 9824578
[TBL] [Abstract][Full Text] [Related]
2. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
[TBL] [Abstract][Full Text] [Related]
4. Influence of anti-rheumatic drugs on gut permeability and on the gut associated lymphoid tissue.
Bjarnason I; Peters TJ
Baillieres Clin Rheumatol; 1996 Feb; 10(1):165-76. PubMed ID: 8674146
[TBL] [Abstract][Full Text] [Related]
5. Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine.
Bours MJ; Troost FJ; Brummer RJ; Bast A; Dagnelie PC
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):245-50. PubMed ID: 17301652
[TBL] [Abstract][Full Text] [Related]
6. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
[TBL] [Abstract][Full Text] [Related]
8. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.
Bjarnason I; Hayllar J; Smethurst P; Price A; Gumpel MJ
Gut; 1992 Sep; 33(9):1204-8. PubMed ID: 1427372
[TBL] [Abstract][Full Text] [Related]
9. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
[TBL] [Abstract][Full Text] [Related]
10. Intestinal permeability in runners in the 1996 Chicago marathon.
Smetanka RD; Lambert GP; Murray R; Eddy D; Horn M; Gisolfi CV
Int J Sport Nutr; 1999 Dec; 9(4):426-33. PubMed ID: 10660873
[TBL] [Abstract][Full Text] [Related]
11. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
Bjarnason I; Takeuchi K
J Gastroenterol; 2009; 44 Suppl 19():23-9. PubMed ID: 19148789
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandin E2 on disease activity, gastric secretion and intestinal permeability, and morphology in patients with rheumatoid arthritis.
Henriksson AE; Tagesson C; Uribe A; Uvnäs-Moberg K; Nord CE; Gullberg R; Johansson C
Ann Rheum Dis; 1988 Aug; 47(8):620-7. PubMed ID: 3166369
[TBL] [Abstract][Full Text] [Related]
13. Differential trafficking of saccharidic probes following aspirin in clinical tests of intestinal permeability in young healthy women.
Sequeira IR; Lentle RG; Kruger MC; Hurst RD
Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):107-17. PubMed ID: 24033480
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of NSAID enteropathy as shown by a simple faecal test.
Tibble JA; Sigthorsson G; Foster R; Scott D; Fagerhol MK; Roseth A; Bjarnason I
Gut; 1999 Sep; 45(3):362-6. PubMed ID: 10446103
[TBL] [Abstract][Full Text] [Related]
15. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?
Jenkins RT; Rooney PJ; Jones DB; Bienenstock J; Goodacre RL
Br J Rheumatol; 1987 Apr; 26(2):103-7. PubMed ID: 3103807
[TBL] [Abstract][Full Text] [Related]
16. Geography of intestinal permeability and absorption.
Menzies IS; Zuckerman MJ; Nukajam WS; Somasundaram SG; Murphy B; Jenkins AP; Crane RS; Gregory GG
Gut; 1999 Apr; 44(4):483-9. PubMed ID: 10075954
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function.
Uil JJ; van Elburg RM; van Overbeek FM; Mulder CJ; VanBerge-Henegouwen GP; Heymans HS
Scand J Gastroenterol Suppl; 1997; 223():70-8. PubMed ID: 9200310
[TBL] [Abstract][Full Text] [Related]
18. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
[TBL] [Abstract][Full Text] [Related]
19. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
